Seoul, South Korea

Soon Kil Ahn

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 8.1

ph-index = 4

Forward Citations = 175(Granted Patents)


Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Innovations by Soon Kil Ahn: Pioneering New Pharmaceutical Solutions**

Introduction

Soon Kil Ahn is a distinguished inventor based in Seoul, South Korea, known for his impactful contributions to the field of pharmaceuticals. With a remarkable total of nine patents to his name, Ahn has focused his research primarily on developing novel compounds that target critical pathways in disease modulation, particularly in cancer and metabolic disorders.

Latest Patents

Among his latest innovations, Soon Kil Ahn has developed a pyridine derivative that inhibits both RAF kinase and vascular endothelial growth factor receptor (VEGFR2). This compound is particularly significant because it offers a potential method for preventing and treating various cancers, including melanoma, colorectal cancer, prostate cancer, and more. The invention outlines a preparation method for this novel pyridine derivative and its pharmaceutical applications, providing a promising avenue for therapeutic interventions in cancers associated with RAS mutations.

Additionally, Ahn has patented a compound that selectively inhibits the 11β-HSD1 enzyme, relevant for conditions such as type II diabetes, insulin resistance, obesity, and metabolic syndrome. This compound, along with its preparation method and pharmaceutical applications, demonstrates Ahn's commitment to creating effective therapies for significant health challenges.

Career Highlights

Throughout his career, Soon Kil Ahn has made notable strides in drug development while working with prominent companies such as Chong Kun Dang Corporation and Chong Kun Dang Pharmaceutical Corporation. His work in these organizations has enabled the translation of his innovative ideas into practical solutions for the pharmaceutical industry.

Collaborations

Ahn has collaborated with esteemed colleagues, including Jung Woo Kim and Nam Song Choi, fostering a dynamic research environment that has contributed to the advancement of their shared goals in drug discovery and development. These collaborations underscore the importance of teamwork in achieving groundbreaking results in the pharmaceutical sector.

Conclusion

Soon Kil Ahn's contributions to pharmaceutical innovations are noteworthy, as he continues to pave the way for new therapeutic options that address critical health issues. His work exemplifies the potential impact of dedicated research and development in creating effective treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…